The enduring success of sildenafil has undeniably influenced the pharmaceutical landscape. However, wagering in companies heavily focused on biosimilars and the declining patent exclusivity surrounding https://optimusbookmarks.com/story21329474/the-blue-pill-and-pharmaceutical-companies-a-uncertain-venture